Self-monitoring of blood pressure during pregnancy

The Blood Pressure management system BPm-Health allows pregnant women to accurately self-monitor blood pressure during pregnancy and enables healthcare professionals to provide remote care for mums-to-be.

The need for safe remote monitoring during the COVID-19 epidemic

There has been an increasing recognition of the benefits from self-monitoring of blood pressure (‘BP’) during pregnancy - see references below. The COVID-19 outbreak is now increasing the need for healthcare professionals to advocate BP self-monitoring to reduce face-to-face consultations for pregnant and postnatal women whilst maintaining care for the woman and her baby.

BPm-Health is aimed at:

Women with chronic hypertension, gestational hypertension, pre-eclampsia

Women determined as high-risk by NICE guidelines

All pregnant women (including those who may need to self-isolate for a period)

NICE Guidelines:

One of the following risk factors:

hypertensive disease during a previous pregnancy
chronic kidney disease
autoimmune disease (e.g. systemic lupus erythematosus orantiphospholipid syndrome)
type 1 or type 2 diabetes

Two of the following risk factors:

first pregnancy
age 40 years or older
pregnancy interval of more than 10 years
body mass index (BMI) of 35 kg/m2 or more family history of pre-eclampsia
multi-fetal pregnancy

Benefits

Improves care

Provides women with advice about blood pressure levels .

Gives control

Self-management gives patients greater control of their blood pressure monitoring while reducing the need for clinical visits.

Provides reassurance

Helps mums-to-be self-monitor blood pressure to protect themselves and their baby.

Easy, accurate monitoring

Provides an easy to use and uniform monitoring system for women during pregnancy and healthcare professionals.

Increases safety

Reduces face-to-face contact to reduce risk associated with COVID-19 infection.

Secure

All patient data is anonymised, securely stored on the cloud as a completely isolated instance with rigorous data security and privacy measures.

BPm is currently in development phase prior to commercial launch following successful academic trials by the University of Oxford.

References

McManus RJ, Mant J,Franssen M, Nickless A, Schwartz C, Hodgkinson J, et al. Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial. Lancet. 2018; 391(10124):949-59.
McManusRJ, Mant J, Bray EP, Holder R, Jones MI, Greenfield S, et al. Telemonitoring and self-management in the control of hypertension (TASMINH2): a randomised controlled trial. Lancet. 2010; 376(9736):163-72.
McManusRJ, Mant J, Haque MS, Bray EP, Bryan S, Greenfield SM, et al. Effect of self-monitoring and medication self-titration on systolic blood pressure in hypertensive patients at high risk of cardiovascular disease: the TASMIN-SR randomized clinical trial. JAMA. 2014;312(8):799-808.
PealingLM, Tucker KL, Mackillop LH, Crawford C, Wilson H, Nickless A, et al. A randomised controlled trial of blood pressure self-monitoring in the management of hypertensive pregnancy. OPTIMUM-BP: A feasibility trial. Pregnancy Hypertens. 2019;18:141-9.
Cairns AE, Tucker KL, Leeson P, Mackillop LH, Santos M, Velardo C, et al. Self-Management of Postnatal Hypertension: The SNAP-HT Trial. Hypertension.2018.
TuckerKL, Taylor KS, Crawford C, Hodgkinson JA, Bankhead C, Carver T, et al. Blood pressure self-monitoring in pregnancy: examining feasibility in a prospective cohort study. BMC Pregnancy Childbirth. 2017;17(1):442.
HintonL, Tucker KL, Greenfield SM, Hodgkinson JA, Mackillop L, McCourt C, et al.Blood pressure self-monitoring in pregnancy (BuMP) feasibility study; a qualitative analysis of women's experiences of self-monitoring. BMC PregnancyChildbirth. 2017;17(1):427.
GrantS, Hodgkinson J, Schwartz C, Bradburn P, Franssen M, Hobbs FR, et al. Using mHealth for the management of hypertension in UK primary care: an embedded qualitative study of the TASMINH4 randomised controlled trial. Br J Gen Pract. 2019;69(686):e612-e20.
JonesMI, Greenfield SM, Bray EP, Baral-Grant S, Hobbs FD, Holder R, et al. Patients' experiences of self-monitoring blood pressure and self-titration of medication: the TASMINH2 trial qualitative study. Br J Gen Pract. 2012;62(595):e135-e42.
Tucker KL, Bowen L, Crawford C, Mallon P,Hinton L, Lee MM, et al. The feasibility and acceptability of self-testing for proteinuria during pregnancy: A mixed methods approach. Pregnancy Hypertens. 2018;12:161-8.

Self-monitoring of blood pressure during pregnancy

Self-monitoring of blood pressure during pregnancy

The Blood Pressure management system BPm-Health allows pregnant women to accurately self-monitor blood pressure during pregnancy and enables healthcare professionals to provide remote care for mums-to-be.

The need for safe remote monitoring during the COVID-19 epidemic

Self-monitoring in pregnancy

Easy to use

Provides advice

BPm-Health is aimed at:

NICE Guidelines:

One of the following risk factors:

Two of the following risk factors:

In partnership with

Benefits

Improves care

Gives control

Provides reassurance

Easy, accurate monitoring

Increases safety

Secure

References

CONTACT

FOLLOW US

EXPLORE

PRODUCTS

FURTHER LINKS

LEGAL

EXPLORE

Further links

PRODUCTS

Follow US

Legal

Contact